无阿片类药物麻醉与阿片类药物节约型麻醉对术后谵妄的影响:系统评价与荟萃分析。
完整摘要 · 中文译文
背景:术后谵妄(POD)是一种常见的神经认知状况,与发病率增加、长期认知功能下降和死亡相关。围手术期阿片类药物暴露可能通过镇静、神经炎症和神经递质失调促进谵妄的发生。使用氯胺酮、艾司氯胺酮和右美托咪定等药物的无阿片类药物麻醉和阿片类药物节约型麻醉已成为减少POD的潜在策略。本荟萃分析评估了无阿片类药物和阿片类药物节约型麻醉方案对成人手术患者POD的影响。 方法:检索Embase、PubMed和Web of Science,检索时间从建库至2026年4月。纳入比较以氯胺酮、艾司氯胺酮或右美托咪定为基础的无阿片类药物和阿片类药物节约型策略与安慰剂、常规阿片类药物麻醉或标准治疗的随机对照试验。主要结局为POD。采用随机效应模型合并风险比(RR)及其95%置信区间(CI)。 结果:共分析41项随机对照试验,涉及7852例患者。在接受无阿片类药物/阿片类药物节约型干预的4013例患者中,488例发生POD;在3839例对照中,633例发生POD。总体而言,这些策略显著降低了谵妄风险(RR = 0.641,95% CI:0.525-0.784;I2 = 52.2%)。亚组分析显示艾司氯胺酮(RR = 0.745,95% CI:0.526-1.053)和右美托咪定(RR = 0.612,95% CI:0.471-0.796)可降低风险,而氯胺酮显示出无显著意义的获益趋势(RR = 0.598,95% CI:0.251-1.423)。未发现显著的发表偏倚 检出。 结论:无阿片类药物及少阿片类药物麻醉策略可减少成年手术患者的术后谵妄(POD),其中右美托咪定和艾司氯胺酮显示出最为一致的获益。这些发现支持采用多模式少阿片类药物麻醉以实现围手术期神经认知保护。
完整摘要 · 英文原文
BACKGROUND: Postoperative delirium (POD) is a common neurocognitive condition linked with increased morbidity, long-term cognitive decline, and death. Perioperative opioid exposure may contribute to delirium through sedation, neuroinflammation, and neurotransmitter dysregulation. Opioid-free anesthesia and opioid-sparing anesthesia using agents such as ketamine, esketamine, and dexmedetomidine have emerged as a potential strategy to reduce POD. This meta-analysis evaluated the effects of opioid-free and opioid-sparing anesthetic regimens on POD in adult surgical patients. METHODS: Embase, PubMed, and Web of Science were searched from inception to April 2026. Randomized controlled trials comparing ketamine-, esketamine-, or dexmedetomidine-based opioid-free and opioid-sparing strategies with placebo, conventional opioid-based anesthesia, or standard care were included. The primary outcome was POD. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. RESULTS: Forty-one randomized controlled trials involving 7852 patients were analyzed. POD occurred in 488 of 4013 patients receiving opioid-free/opioid-sparing interventions and 633 of 3839 controls. Overall, these strategies significantly reduced the risk of delirium (RR = 0.641, 95% CI: 0.525-0.784; I2 = 52.2%). Subgroup analyses showed reductions with esketamine (RR = 0.745, 95% CI: 0.526-1.053) and dexmedetomidine (RR = 0.612, 95% CI: 0.471-0.796), while ketamine demonstrated a nonsignificant trend toward benefit (RR = 0.598, 95% CI: 0.251-1.423). No significant publication bias was detected. CONCLUSIONS: Opioid-free and opioid-sparing anesthetic strategies reduce POD in adult surgical patients, with dexmedetomidine and esketamine showing the most consistent benefits. These findings support multimodal opioid-sparing anesthesia for perioperative neurocognitive protection.